Evidence map›Paper›PMID 40150714›Full record

ArticleBioengineering (Basel, Switzerland)2025

Identifying Hypertrophic or Dilated Cardiomyopathy: Development and Validation of a Fine-Tuned ResNet50 Model Based on Electrocardiogram Image.

Jiayu Xu, Bo Chen, Weiyang Liu, Wei Dong, Yan Zhuang, Peifang Zhang, Kunlun He

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jiayu XuGraduate School, Chinese People's Liberation Army General Hospital, Beijing 100853, China.
Bo ChenMedical Innovation Research Division, Chinese People's Liberation Army General Hospital, Beijing 100853, China.
Weiyang LiuGraduate School, Chinese People's Liberation Army General Hospital, Beijing 100853, China.
Wei DongCardiology Department, Sixth Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100853, China.
Yan ZhuangMedical Innovation Research Division, Chinese People's Liberation Army General Hospital, Beijing 100853, China.
Peifang ZhangBiomind Technology Inc., Beijing 101300, China.
Kunlun HeMedical Innovation Research Division, Chinese People's Liberation Army General Hospital, Beijing 100853, China.ORCID 0000-0002-3335-5700

Funding

National Science and Technology Major Project of the Ministry of Science and Technology of China 2021ZD0140408
6 · The paper itself

Abstract

There is no established detecting tool for hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). This study aimed to develop a deep-learning-based model for identifying HCM and DCM using standard 12-lead electrocardiogram (ECG) images. We obtained a cohort of patients with HCM (171 ECG images) or DCM (364 ECG images), confirmed by cardiovascular magnetic resonance (CMR) examinations, who underwent both ECG and CMR within 30 days at our institution. Age- and sex-matched healthy controls (2314 ECG images) were selected from our Health Check Center. A total of 2849 ECG images were processed via a fine-tuned ResNet50 architecture, with stratified five-fold cross-validation for model training, validation, and testing. The proposed model demonstrated strong performance in distinguishing DCM, achieving an area under the receiver operating curve (AUROC) of 0.996 and an area under the precision-recall curve (AUPRC) of 0.940. For the detection of HCM, the model also achieved an AUROC of 0.980 and an AUPRC of 0.953, respectively. The model prospectively exhibited stability in temporal validation. Furthermore, representative images of the Gradient-weighted Class Activation Mapping (Grad-CAM) technique analysis showed the regions corresponding to the anterior and anteroseptal leads were the most important areas for the prediction of HCM or DCM. This temporally validated fine-tuned ResNet50 model shows promise to inexpensively detect individuals with HCM or DCM.

Indexed as

artificial intelligencediagnosisdilated cardiomyopathyelectrocardiogram imagehypertrophic cardiomyopathy

Identifiers

PMID40150714
PMCPMC11939401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.